ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹3,995 Cr | ₹3,707 Cr | ₹4,805 Cr | ₹3,604 Cr | ₹3,245 Cr |
What is the latest Total Current Liabilities ratio of ALKEM LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹3,995 Cr |
Mar2023 | ₹3,707 Cr |
Mar2022 | ₹4,805 Cr |
Mar2021 | ₹3,604 Cr |
Mar2020 | ₹3,245 Cr |
How is Total Current Liabilities of ALKEM LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3,995 Cr | 7.75 | |
Mar2023 | ₹3,707 Cr | -22.85 | |
Mar2022 | ₹4,805 Cr | 33.33 | |
Mar2021 | ₹3,604 Cr | 11.08 | |
Mar2020 | ₹3,245 Cr | - |
Compare Total Current Liabilities of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹60,096.6 Cr | 2.2% | -9.4% | 2.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | -2.4% | -7.2% | 27.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 0% | -9.2% | 61.5% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 6% | -3.8% | 10.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 1.7% | -11.4% | 2.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 5.2% | -2.1% | 26.1% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | 2.2% |
-9.4% |
2.2% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses